Rigel Pharmaceuticals, Inc.RIGLNASDAQ
Loading
Operating cash flow minus capital expenditures
Latest
$75.66M
↑ 358% vs avg
Percentile
P100
Near historical high
Streak
3 yr
Consecutive growthExpanding
Average
$-29.37M
Historical baseline
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $75.66M | +143.5% |
| 2024 | $31.07M | +249.8% |
| 2023 | $-20.74M | +72.0% |
| 2022 | $-74.21M | -1513.2% |
| 2021 | $5.25M | +109.8% |
| 2020 | $-53.45M | -24.4% |
| 2019 | $-42.97M | +28.3% |
| 2018 | $-59.93M | +22.9% |
| 2017 | $-77.72M | -1.3% |
| 2016 | $-76.69M | - |